Wells Fargo & Company Comera Life Sciences Holdings, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.29 - $0.68 $3 - $7	-11 Reduced 11.46%	85 $0
Q2 2023 Aug 15, 2023	BUY	$0.4 - $0.89 $8 - $17	20 Added 26.32%	96 $0
Q1 2023 May 12, 2023	BUY	$0.84 - $1.9 $20 - $45	24 Added 46.15%	76 $0
Q4 2022 Feb 13, 2023	SELL	$1.2 - $1.93 $7 - $11	-6 Reduced 10.34%	52 $0
Q3 2022 Nov 14, 2022	BUY	$0.09 - $4.01 $5 - $232	58 New	58 $0

Ticker CMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,087,200
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.